IRADIMED CORP - Common Stock (IRMD)

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
6,792,851
Share change
+68,870
Total reported value
$298,497,413
Put/Call ratio
1.4%
Price per share
$43.94
Number of holders
137
Value change
+$3,015,641
Number of buys
75
Number of sells
31

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2024

As of 30 Jun 2024, IRADIMED CORP - Common Stock (IRMD) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,792,851 shares. The largest 10 holders included Nine Ten Capital Management LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Copeland Capital Management, LLC, Bares Capital Management, Inc., Ranger Investment Management, L.P., DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and RK Capital Management, LLC. This page lists 137 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.